The vehicle-treated APP/PS1 mice exhibited 35% reduction in spontaneous alternation behavior (Mann–Whitney nonparametric test: p < 0.0001), consistent with episodic memory deficits reported for this transgenic AD model [14,28]. The gene discussed is APP; the disease is Alzheimer disease.